Endothelin-1 production during the acute chest syndrome in sickle cell disease

American Journal of Respiratory and Critical Care Medicine

Volumn 156, Issue 1, 1997, Pages 280-285

  Hammerman, Samuel I ^b   Kourembanas, Stella ^b   Conca, Tammy J ^b   Tucci, Marisa ^b   Brauer, Mark ^b   Farber, Harrison W ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1;

ANIMAL CELL; ARTICLE; COUGHING; FEVER; LUNG DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SICKLE CELL ANEMIA; THORAX PAIN;

EID: 0030739926     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.156.1.9611085     Document Type: Article

References (30)

1. Thomas, A. N., C. Pattison, and G. R. Serjeant. 1982. Causes of death in sickle cell disease in Jamaica. B.M.J. 285:633-635.
2. Johnson, C. S., and T. D. Verdigem. 1988. Pulmonary complications of sickle cell disease. Semin. Respir. Med. 9:287-246.
3. Kirkpatrick, M. B., and J. B. Bass. 1989. Pulmonary complications in adults with sickle cell disease. Pulm. Perspectives 6:6-10.
4. Hassel, K. L., J. R. Eckman, and P. A. Lane. 1994. Acute multiorgan failure syndrome: a potentially catastrophic complication of severe sickle cell pain episodes. Am. J. Med. 96:155-162.
5. Barrett-Connor, E. 1971. Bacterial infection and sickle cell anemia. Medicine 50:97-112.
6. Charache, S., J. C. Scott, and P. Charache. 1979. Acute chest syndrome in adults with sickle cell anemia. Arch. Intern. Med. 139:67-69.
7. Haupt, H. M., G. W. Moore, T. W. Bauer, and G. M. Hutchins. 1982. The lung in sickle cell disease. Chest 81:332-337.
8. Vichinsky, C., R. Williams, M. Das, A. N. Earles, N. Lewis, A. Adler, and J. McQuitty. 1994. Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia. Blood 83:3107-3112.
9. Powars, D., J. A. Weidman, T. Odom-Maryon, J. C. Niland, and C. Johnson. 1988. Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine 67:66-76.
10. Collins, F. S., and E. P. Orringer. 1982. Pulmonary hypertension and cor pulmonale in sickle hemoglobinopathies. Am. J. Med. 73:814-821.
11. Platt, O. S., D. J. Brambilla, W. F. Rosse, P. F. Milner, O. Castro, M. H. Steinberg, and P. P. Klug. 1994. Mortality in sickle cell disease: life expectancy and risk factors for early death. N. Engl. J. Med. 330:1639-1644.
12. Hebbel, R. P., O. Yamada, C. F. Moldow, H. S. Jacob, J. G. White, and J. W. Eaton. 1980. Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease. J. Clin. Invest. 63:154-160.
13. Hebbel, R. P., C. F. Moldow, and M. H. Steinberg. 1981. Modulation of erythrocyte-endothelial interactions and the vasoocclusive severity of sickling disorders. Blood 58:947-952.
14. Kaul, D. K., M. E. Fabry, and R. L. Nagel. 1989. Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications. Proc. Natl. Acad. Sci. U.S.A. 89:3356-3360.
15. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 322: 411-415.
16. Longenecker, G., D. Culbertson, B. Beyers, E. Manci, and V. Mankad. 1995. Plasma endothelin (ET) levels are evaluated in sickle cell disease (SCD) (abstract). Blood 78:1645a.
17. Tretyakov, A., and H. W. Farber. 1995. Endothelial cell tolerance to hypoxia: potential role of purine nucleotide phosphates. J. Clin. Invest. 95:738-744.
18. Graven, K. K., R. F. Troxler, H. Kornfeld, M. V. Panchenko, and H. W. Farber. 1994. Regulation of endothelial cell glyceraldehyde-3-phosphate dehydrogenase expression by hypoxia. J. Biol. Chem. 269: 24446-24453.
19. Stockman, J. A., M. A. Nigro, M. M. Mishkin, and F. A. Oski. 1972. Occlusion of large cerebral vessels in sickle-cell anemia. N. Engl. J. Med. 287:846-849.
20. Moser, K. M., and J. G. Shea. 1957. The relationship between pulmonary infarction, cor pulmonale, and the sickle states. Am. J. Med. 22:561-579.
21. Klug, P., N. Kaye, and W. Jensen. 1982. Endothelial cell and vascular damage in the sickle cell disorders. Blood Cells 8:175-184.
22. Setty, B. N., C. D. Dampier, and M. J. Stuart. 1995. Arachidonic acid metabolites are involved in mediating red blood cell adherence to endothelium. J. Lab. Clin. Med. 125:608-617.
23. Mohandas, N., and E. Evans. 1984. Adherence of sickle erythrocytes to vascular endothelial cells: requirement for both cell membrane changes and plasma factors. Blood 64:282-287.
24. Mosseri, M., A. N. Bartlett-Pandite, K. Wenc, J. M. Isner, and R. Weinstein. 1993. Inhibition of endothelium-dependent vasorelaxation by sickle erythrocytes. Am. Heart J. 126:338-346.
25. Hatch, F. E., L. R. Crowe, D. E. Miles, J. P. Young, and A. Portner, 1989. Altered vascular reactivity in sickle cell hemoglobinopathy: a possible protective factor from hypertension. Am. J. Hypertens. 2:2-8.
26. Lipowsky, H. H., N. U. Sheikh, and D. M. Katz. 1987. Intravital microscopy of capillary hemodynamics in sickle cell disease. J. Clin. Invest. 80:117-127.
27. Wautier, J., D. Pintigny, J. Maelouf, M. Wautier, E. Corvazier, and J. Caen. 1986. Release of prostacyclin after erythrocyte adhesion to cultured vascular endothelium. J. Lab. Clin. Med. 107:210-215.
28. Setty, B. N., D. Chen, and M. J. Stuart. 1995. Sickle cell vaso-occlusive crisis is associated with abnormalities in the ratio of vasoconstrictor to vasodilator prostanoids. Pediatr. Res. 38:95-102.
29. Setty, B. N. Y., D. Chen, and M. J. Stuart. 1996. Sickle red blood cells stimulate endothelial cell production of eicosanoids and diacylglycerol. J. Lab. Clin. Med. 128:313-321.
30. Phelan, M., S. P. Perrine, M. Brauer, and D. V. Faller. 1995. Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture. J. Clin. Invest. 96:1145-1151.